drugset / Trial / NCT00407524

AKL 1 Asthma Study

NCT00407524 ↗

Phase 2 Completed 40 enrolled University of Aberdeen
RandomizedCrossoverDouble-blind

Summary

This study aims to provide scientific evidence of the efficacy and safety of this agent as 'add-on' therapy for adult patients whose asthma remains uncontrolled on standard medication. The aims are to assess the efficacy, safety and tolerability of AKL 1 companred to placebo in the treatment of asthma.

Timeline

Start
2003-10
Primary completion
—
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AKL1 Unknown — —

Indications